• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血细胞指标在进展至终末期肾病过程中的作用。

Role of Blood Cell Indexes in Progresses to ESRD.

作者信息

Lan Duong Thi Ngoc, Coradduzza Donatella, Van An Le, Paliogiannis Panagiotis, Chessa Carla, Zinellu Angelo, Mangoni Arduino A, Carru Ciriaco

机构信息

Department of General Internal Medicine and Endocrinology, Hue University of Medicine and Pharmacy, Hue University, Hue, Vietnam.

Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

出版信息

Indian J Clin Biochem. 2025 Apr;40(2):307-315. doi: 10.1007/s12291-024-01184-1. Epub 2024 Feb 13.

DOI:10.1007/s12291-024-01184-1
PMID:40123629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11928694/
Abstract

Chronic kidney disease (CKD) is a complex health condition characterized by the gradual loss of renal function, often leading to end-stage renal disease (ESRD). It results from a combination of medical, environmental, and genetic factors. Predicting the rate of renal function decline and effectively managing the progression to ESRD is challenging in clinical practice. CKD assessment involves various indicators, including estimated glomerular filtration rate (eGFR), albuminuria levels, serum creatinine, and others. This study aimed to explore the predictive potential of specific blood cell indexes in forecasting further renal function decline and the transition from CKD stage 3-4 to ESRD. We assessed the following blood cell indexes in 377 CKD stage 3-4 patients: absolute neutrophil count (ANC), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), derived NLR (dNLR), mean platelet volume (MPV), aggregate index of systemic inflammation (AISI), and systemic inflammation index (SII). ANC, MPV, NLR, PLR, dNLR, and SII were found to independently predict a rapid decline in eGFR. Notably, NLR and dNLR demonstrated the highest sensitivity and specificity with cut-off values of 3.36 and 2.45, respectively (NLR: 88.6 and 81.7%; dNLR: 85.2 and 75.8%). The corresponding area under the ROC curve values were 0.877 (95% CI 0.837-0.918,  < 0.001) for NLR and 0.849 (95% CI 0.805-0.892,  < 0.001) for dNLR. However, none of the blood cell indexes independently predicted the transition to ESRD. The NLR and the dNLR exhibited the highest predictive capacity towards a rapid decline in renal function in CKD. No blood cell index, however, independently predicted the transition into ERSD.

摘要

慢性肾脏病(CKD)是一种复杂的健康状况,其特征是肾功能逐渐丧失,常导致终末期肾病(ESRD)。它是由医学、环境和遗传因素共同作用导致的。在临床实践中,预测肾功能下降的速度并有效管理向ESRD的进展具有挑战性。CKD评估涉及多种指标,包括估计肾小球滤过率(eGFR)、蛋白尿水平、血清肌酐等。本研究旨在探讨特定血细胞指标在预测肾功能进一步下降以及从CKD 3-4期向ESRD转变方面的预测潜力。我们评估了377例CKD 3-4期患者的以下血细胞指标:绝对中性粒细胞计数(ANC)、中性粒细胞/淋巴细胞比值(NLR)、血小板/淋巴细胞比值(PLR)、衍生NLR(dNLR)、平均血小板体积(MPV)、全身炎症聚集指数(AISI)和全身炎症指数(SII)。发现ANC、MPV、NLR、PLR、dNLR和SII可独立预测eGFR的快速下降。值得注意的是,NLR和dNLR表现出最高的敏感性和特异性,截断值分别为3.36和2.45(NLR:88.6%和81.7%;dNLR:85.2%和75.8%)。NLR的ROC曲线下面积值为0.877(95%CI 0.837-0.918,P<0.001),dNLR为0.849(95%CI 0.805-0.892,P<0.001)。然而,没有一个血细胞指标能独立预测向ESRD的转变。NLR和dNLR对CKD患者肾功能快速下降的预测能力最强。然而,没有血细胞指标能独立预测向ESRD的转变。

相似文献

1
Role of Blood Cell Indexes in Progresses to ESRD.血细胞指标在进展至终末期肾病过程中的作用。
Indian J Clin Biochem. 2025 Apr;40(2):307-315. doi: 10.1007/s12291-024-01184-1. Epub 2024 Feb 13.
2
[The relationship between the comprehensive blood inflammation indexes and stage I pneumoconiosis and its combined lung infections].[全血炎症指标与一期尘肺及其合并肺部感染的关系]
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2024 May 20;42(5):350-355. doi: 10.3760/cma.j.cn121094-20231010-00081.
3
COMPLETE BLOOD COUNT DERIVED INFLAMMATORY BIOMARKERS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES.血液系统恶性肿瘤患者全血细胞计数衍生的炎症生物标志物
Georgian Med News. 2020 May(302):39-44.
4
Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients.白细胞及全身炎症指标(中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、单核细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值、中性粒细胞与淋巴细胞比值乘积、急性炎症严重指数、全身炎症反应指数-I和全身炎症反应指数)在入院时的作用可预测非老年和老年COVID-19患者的院内死亡率。
Front Med (Lausanne). 2022 Aug 18;9:916453. doi: 10.3389/fmed.2022.916453. eCollection 2022.
5
Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.术前炎症标志物对胶质瘤患者的诊断价值:一项多中心队列研究。
J Neurosurg. 2018 Sep;129(3):583-592. doi: 10.3171/2017.3.JNS161648. Epub 2017 Nov 3.
6
The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting testicular germ cell tumors: A retrospective clinical study.全身免疫炎症指数和中性粒细胞与淋巴细胞比值在预测睾丸生殖细胞肿瘤中的价值:一项回顾性临床研究
Front Oncol. 2022 Sep 16;12:893877. doi: 10.3389/fonc.2022.893877. eCollection 2022.
7
Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy.免疫炎症生物标志物对预测接受放化疗的非小细胞肺癌患者生存和放疗敏感性的预后影响。
J Med Imaging Radiat Oncol. 2022 Feb;66(1):146-157. doi: 10.1111/1754-9485.13341. Epub 2021 Oct 10.
8
Diagnostic Value of Inflammatory Factors in Pathology of Bladder Cancer Patients.炎症因子在膀胱癌患者病理中的诊断价值
Front Mol Biosci. 2020 Nov 5;7:575483. doi: 10.3389/fmolb.2020.575483. eCollection 2020.
9
The correlation of systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, derived neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with disease severity in recurrent aphthous stomatitis.复发性阿弗他溃疡患者的全身免疫炎症指数、中性粒细胞与淋巴细胞比值、衍生中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值与疾病严重程度的相关性。
J Cosmet Dermatol. 2022 Oct;21(10):4858-4863. doi: 10.1111/jocd.14838. Epub 2022 Feb 18.
10
The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients.入院时的全身炎症指数可预测 COVID-19 患者的住院死亡率。
Molecules. 2020 Dec 4;25(23):5725. doi: 10.3390/molecules25235725.

引用本文的文献

1
Prognostic value of neutrophil-to-lymphocyte ratio for the clinical outcomes of chronic kidney diseases: an update systematic review and meta-analysis.中性粒细胞与淋巴细胞比值对慢性肾脏病临床结局的预后价值:一项更新的系统评价和荟萃分析
BMC Nephrol. 2025 Jul 28;26(1):419. doi: 10.1186/s12882-025-04363-1.

本文引用的文献

1
Quantitative Metabolomics to Explore the Role of Plasma Polyamines in Colorectal Cancer.定量代谢组学探讨血浆多胺在结直肠癌中的作用。
Int J Mol Sci. 2022 Dec 21;24(1):101. doi: 10.3390/ijms24010101.
2
Potential Utility of Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and Neutrophil, Lymphocyte, and Platelet Ratios in Differential Diagnosis of Kidney Transplant Acute Rejection: A Retrospective, Propensity Score Matched Analysis.中性粒细胞与淋巴细胞、血小板与淋巴细胞以及中性粒细胞、淋巴细胞和血小板比值在肾移植急性排斥反应鉴别诊断中的潜在应用:一项回顾性、倾向评分匹配分析。
Ann Transplant. 2022 Dec 20;27:e937239. doi: 10.12659/AOT.937239.
3
Role of Polyamines as Biomarkers in Lymphoma Patients: A Pilot Study.
多胺作为淋巴瘤患者生物标志物的作用:一项初步研究。
Diagnostics (Basel). 2022 Sep 4;12(9):2151. doi: 10.3390/diagnostics12092151.
4
miRNAs as Molecular Biomarkers for Prostate Cancer.miRNAs 作为前列腺癌的分子生物标志物。
J Mol Diagn. 2022 Nov;24(11):1171-1180. doi: 10.1016/j.jmoldx.2022.05.005. Epub 2022 Jul 11.
5
Multimorbidity matters in low and middle-income countries.多重疾病在低收入和中等收入国家至关重要。
J Multimorb Comorb. 2022 Jun 16;12:26335565221106074. doi: 10.1177/26335565221106074. eCollection 2022 Jan-Dec.
6
Epidemiology of chronic kidney disease: an update 2022.慢性肾脏病流行病学:2022年最新情况
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.
7
Plasma Polyamine Biomarker Panels: Agmatine in Support of Prostate Cancer Diagnosis.血浆多胺生物标志物谱:胍丁胺支持前列腺癌诊断。
Biomolecules. 2022 Mar 29;12(4):514. doi: 10.3390/biom12040514.
8
Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study.全球、区域和国家 70 岁及以上成年人的疾病和伤害负担:全球疾病负担 2019 研究的系统分析。
BMJ. 2022 Mar 10;376:e068208. doi: 10.1136/bmj-2021-068208.
9
A preliminary study procedure for detection of polyamines in plasma samples as a potential diagnostic tool in prostate cancer.一种将血浆样本中多胺检测作为前列腺癌潜在诊断工具的初步研究程序。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jan 1;1162:122468. doi: 10.1016/j.jchromb.2020.122468. Epub 2020 Nov 30.
10
Prevalence and Disease Burden of Chronic Kidney Disease.慢性肾脏病的患病率和疾病负担。
Adv Exp Med Biol. 2019;1165:3-15. doi: 10.1007/978-981-13-8871-2_1.